Johnson & Johnson reported big second-quarter sales gains last week in its Jacksonville-based vision care business as it rebounded from last year’s COVID-19 pandemic shutdowns.
And company officials project continued strong gains in the business beyond the COVID recovery.
“I expect vision to accelerate given a lot of the new product launches,” said Ashley McEvoy, chairman of Johnson & Johnson’s medical devices business, in the company’s quarterly conference call.
Johnson & Johnson Vision, which produces contact lenses and eye surgical products, reported second-quarter sales jumped 70.1% from the second quarter of 2020 to $1.183 billion.
Read the rest of this story from WJCT News partner the Jax Daily Record.
